In conclusion, we screened and validated the differentiated expressed ferroptosis-related genes GPX3, CDKN2A, and SLC7A11, which may serve as novel prognostic biomarkers for patients with CRC. The gene discussed is CDKN2A; the disease is colorectal carcinoma.